Caxton Associates (New York)’s eHealth EHTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-22,551
Closed -$211K – 542
2023
Q1
$211K Buy
+22,551
New +$177K 0.03% 412
2022
Q4
– Sell
-65,665
Closed -$257K – 497
2022
Q3
$257K Buy
65,665
+9,029
+16% +$63K 0.03% 351
2022
Q2
$528K Buy
56,636
+26,615
+89% +$271K 0.05% 258
2022
Q1
$373K Buy
30,021
+21,736
+262% +$374K 0.03% 321
2021
Q4
$211K Sell
8,285
-1,278
-13% -$42.5K 0.02% 484
2021
Q3
$387K Buy
9,563
+5,438
+132% +$253K 0.04% 269
2021
Q2
$241K Buy
+4,125
New +$271K 0.03% 371
2019
Q3
– Sell
-4,604
Closed -$396K – 430
2019
Q2
$396K Sell
4,604
-3,962
-46% -$267K 0.05% 232
2019
Q1
$534K Buy
+8,566
New +$472K 0.08% 136

Other funds holding EHTH

Caxton Associates (New York)'s EHTH Position: Q2 2023 in Review

Caxton Associates (New York) sold out of eHealth (EHTH) in Q2 2023, closing a stake of 22,551 shares — an estimated $211K sold.

Caxton Associates (New York) first reported a position in EHTH in Q1 2019 and held it in 9 quarters. The position peaked at $534K in Q1 2019. 116 funds tracked by Wall St. Rank hold EHTH as of Q2 2023.

  • Caxton Associates (New York) reported no remaining eHealth position as of Q2 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 22,551 eHealth shares in Q2 2023, an estimated $211K.
  • Caxton Associates (New York) first reported a position in eHealth in Q1 2019 and held it in 9 quarters.
  • Caxton Associates (New York)'s eHealth position peaked at $534K in Q1 2019.
  • 116 funds tracked by Wall St. Rank held eHealth as of Q2 2023.

Based on Caxton Associates (New York)'s 13F filing for Q2 2023, filed 15 Aug 2023.